Altria Group has released its third-quarter results following its letter to the US Food and Drug Administration (FDA), in which the company announced it would remove most of its non-tobacco e-liquids and pods from the US market.
The results indicate that a substantial majority of the volume from Nu Mark – Altria’s “innovation company” for vapour products – will survive the commitment.
In releasing the results, Altria said: “Approximately 80% of Nu Mark’s e-vapor volume in the third-quarter of 2018 will remain on the market after removing MarkTen Elite and Apexby MarkTen pod-based products and discontinuing the sale of flavor variants of Nu Mark’s cig-a-like products, other than tobacco, menthol and mint varieties.”